Tim O. Lankisch

Cutting Edge: Identification and Characterization of Human Intrahepatic CD49a+ NK Cells

Nicole Marquardt, Vivien Béziat, Sanna Nyström et al. · The Journal of Immunology · 2015 · 246 citations

Life Sciences, Cell Biology, Immunology +12

Implementation of proteomic biomarkers: making it work

Harald Mischak, John P. A. Ioannidis, Àngel Argilés et al. · European Journal of Clinical Investigation · 2012 · 169 citations · Full text

Pharmacy, Biomedical Sciences, Biostatistics +17

Bile Proteomic Profiles Differentiate Cholangiocarcinoma From Primary Sclerosing Cholangitis and Choledocholithiasis §Δ

Tim O. Lankisch, Jochen Metzger, Ahmed Negm et al. · Hepatology · 2010 · 162 citations · Full text

Medicine, Biochemistry, Pathology +17

Gilbert's disease and atazanavir: From phenotype to UDP-glucuronosyltransferase haplotype

Tim O. Lankisch, Ulrike Moebius, Michael Wehmeier et al. · Hepatology · 2006 · 138 citations · Full text

Life Sciences, Genetics, Pharmacotherapy +13

Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders

Jochen Metzger, Ahmed Negm, Ruben R. Plentz et al. · Gut · 2012 · 135 citations

Medicine, Molecular Medicine, Pathology +17